Literature DB >> 70387

Early lesions and development of primary hepatocellular carcinoma in man--association with hepatitis B viral infection.

K Okita, T Kodama, T Harada, K Noda, Y Fukumoto.   

Abstract

It is well known that primary hepatocellular carcinoma could be derived from chronic hepatitis and liver cirrhosis in epidemiologic studies. However, it is still not clear what kinds of hepatocyte are premalignant cells. Recently we have focused on liver cell dysplasia as a possible premalignant cell, and showed localization of alpha-fetoprotein in the cytoplasma of these cells. Although the dysplastic cells were often seen in the liver of chronic active hepatitis, hepatitis B virus associated DNA polymerase activity was also significantly high in the sera from the patients with chronic active hepatitis. In this paper, we discuss the possible role of hepatitis B virus through hepatocarcinogenesis in human.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 70387     DOI: 10.1007/BF02773626

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  27 in total

1.  Definition and classification of malignant epithelial neoplasms of the liver.

Authors:  J HIGGINSON; P E STEINER
Journal:  Acta Unio Int Contra Cancrum       Date:  1961

2.  Similarities in the sequence of early histological changes induced in the liver of the rat by ethionine, 2-acetylamino-fluorene, and 3'-methyl-4-dimethylaminoazobenzene.

Authors:  E FARBER
Journal:  Cancer Res       Date:  1956-02       Impact factor: 12.701

3.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

4.  Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan.

Authors:  M J Tong; S C Sun; B T Schaeffer; N K Chang; K J Lo; R L Peters
Journal:  Ann Intern Med       Date:  1971-11       Impact factor: 25.391

5.  D.N.A. polymerase in preparations containing Australia antigen.

Authors:  S Z Hirschman; S J Vernace; F Schaffner
Journal:  Lancet       Date:  1971-05-29       Impact factor: 79.321

6.  Localization of -fetoprotein in hepatoma tissues by immunofluorescence.

Authors:  M Nishioka; T Ibata; K Okita; T Harada; T Fujita
Journal:  Cancer Res       Date:  1972-01       Impact factor: 12.701

7.  S.H. antigen and chronic liver disease.

Authors:  A M Prince; L Leblanc; K Krohn; R Masseyeff; M E Alpert
Journal:  Lancet       Date:  1970-10-03       Impact factor: 79.321

8.  Hepatitis-associated antigen in Ugandan patients with hepatocellular carcinoma.

Authors:  C L Vogel; P P Anthony; N Mody; L F Barker
Journal:  Lancet       Date:  1970-09-26       Impact factor: 79.321

9.  Australia antigen and primary liver cancer.

Authors:  C G Moertel; G J Gleich; E W Hull
Journal:  Am J Dig Dis       Date:  1970-11

10.  Antibody to hepatitis-B core antigen in patients with primary hepatic carcinoma.

Authors:  P Maupas; B Werner; B Larouzé; I Millman; W T London; A O'Connell; B S Blumberg
Journal:  Lancet       Date:  1975-07-05       Impact factor: 79.321

View more
  1 in total

1.  Immunoelectron microscopic observation of alpha-fetoprotein synthesis in human non-malignant liver tissues using immunoperoxidase methods.

Authors:  S Kinoyama; G Yamada; H Okushin; H Mimura; T Kobayashi; T Tsuji
Journal:  Gastroenterol Jpn       Date:  1988-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.